Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 99 filings
- On EDGAR
- CIK 2091349
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 3
News 8 of 9
Prospectuses and Registrations 8
- 424B3 Prospectus supplement for an offering Nov 4, 2026
- 424B3 Prospectus supplement for an offering Nov 4, 2026
- S-1 Registration statement for an offering Oct 26, 2026
- 424B3 Prospectus supplement for an offering Aug 13, 2026
- 424B3 Prospectus supplement for an offering May 15, 2026
- 424B3 Prospectus supplement for an offering May 14, 2026
- S-1 Registration statement for an offering May 8, 2026
- S-8 Registration statement for an employee plan Apr 17, 2026
Ownership 8 of 69
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Nov 3, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- 4 Insider reported a trade Sep 17, 2026
- 4 Insider reported a trade Sep 4, 2026
Other 8 of 10
- EFFECT Notice that a registration became effective Oct 29, 2026
- EFFECT Notice that a registration became effective May 12, 2026
- CORRESP Reply to SEC staff May 8, 2026
- UPLOAD Comment letter from SEC staff May 6, 2026
- DRS Draft registration statement, submitted confidentially May 1, 2026
- SEC STAFF ACTION Apr 1, 2026
- CERT Exchange certified a listing Apr 1, 2026
- 10-12B/A Amended filing Mar 27, 2026
Everything here comes from First Tracks Biotherapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.